Prescription drug · ANDA
Prazosin Hydrochloride NDC 70010-084
Prazosin hydrochloride 1 mg/1 · Capsule · Oral · Granules Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70010-084-01 | 70010008401 | 100 CAPSULE in 1 BOTTLE (70010-084-01)Marketed from Jan 3, 2022 | |
| 70010-084-10 | 70010008410 | 1000 CAPSULE in 1 BOTTLE (70010-084-10)Marketed from Jan 3, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Prazosin Hydrochloride
- Generic name (nonproprietary)
- prazosin hydrochloride
- Active ingredients
- Prazosin hydrochloride — 1 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214608
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha-Antagonists (Mechanism)
- Identifiers
- Product ID 70010-084_253979ce-5078-deec-e063-6294a90a5c52SPL ID 253979ce-5078-deec-e063-6294a90a5c52SPL set ID d01b8927-a422-43b3-89de-088506fdee3cRxCUI 198141, 312593, 312594UNII X0Z7454B90UPC 0370010086012, 0370010084018, 0370010085015
- Pharmacologic class
- alpha-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470010008401followed by a unit qualifier and the quantityPackage 70010-0084-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Prazosin hydrochloride capsules, USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achi…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 214608
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Prazosin Hydrochloride | Prazosin hydrochloride 2 mg/1 | CapsuleOral | Granules Pharmaceuticals Inc. | 70010-085 |
| Prazosin Hydrochloride | Prazosin hydrochloride 5 mg/1 | CapsuleOral | Granules Pharmaceuticals Inc. | 70010-086 |
| Prazosin Hydrochloride | Prazosin hydrochloride 5 mg/1 | CapsuleOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-829 |
| Prazosin Hydrochloride | Prazosin hydrochloride 1 mg/1 | CapsuleOral | Exelan Pharmaceuticals | 76282-721 |
| Prazosin Hydrochloride | Prazosin hydrochloride 2 mg/1 | CapsuleOral | Exelan Pharmaceuticals | 76282-722 |
| Prazosin Hydrochloride | Prazosin hydrochloride 1 mg/1 | CapsuleOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-693 |
| Prazosin Hydrochloride | Prazosin hydrochloride 5 mg/1 | CapsuleOral | Exelan Pharmaceuticals | 76282-723 |
| Prazosin Hydrochloride | Prazosin hydrochloride 2 mg/1 | CapsuleOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-694 |